The current drugs that have been used for treatment of hoFH include Mipomersen, an APOB antisense oligonucleotide, and an MTP inhibitor called Lomitapide, both of which inhibit the assembly of VLDL within hepatocytes. Here, APOB is linked to homozygous familial hypercholesterolemia.